Your browser doesn't support javascript.
loading
Establishment of a human-induced pluripotent stem cell line, KSCBi014-A, from a long QT syndrome type 2 patient harboring a KCNH2 mutation.
Lee, Youngsun; Koo, Soo Kyung; Kim, Jung-Hyun.
Afiliação
  • Lee Y; Division of Intractable Diseases Research, Department of Chronic Diseases Convergence Research, Korea National Institute of Health, Osong Health Technology, Administration Complex 202, South Korea.
  • Koo SK; Division of Intractable Diseases Research, Department of Chronic Diseases Convergence Research, Korea National Institute of Health, Osong Health Technology, Administration Complex 202, South Korea.
  • Kim JH; Division of Intractable Diseases Research, Department of Chronic Diseases Convergence Research, Korea National Institute of Health, Osong Health Technology, Administration Complex 202, South Korea. Electronic address: kjhcorea@korea.kr.
Stem Cell Res ; 57: 102570, 2021 Oct 13.
Article em En | MEDLINE | ID: mdl-34678663
ABSTRACT
Long QT syndrome type 2 (LQT2) is a heart disorder caused by a loss-of-function mutation in the KCNH2 gene that is an essential factor in cardiac repolarization and affects the heart rate. This study has generated a human-induced stem cell line (KSCBi014-A) carrying the KCNH2 (c.453delC) mutation from an LQT2 patient. The non-integrative Sendai virus-mediated induced pluripotent stem cell (iPSC) reprogramming method was used for iPSC line generation. The KSCBi014-A line maintained stem cell-like morphology, normal karyotype, and pluripotency, and could differentiate into three germ layers in vitro.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Stem Cell Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Coréia do Sul

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Stem Cell Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Coréia do Sul